Russel C. Robertson serves as Executive at Valeant Pharmaceuticals International, Inc., where they oversee executive responsibilities. Since joining the company, Russel C. Robertson has executed 54 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 30, 2016 involved receiving (via award) 2,324 shares valued at $33.7K.
Russel C. Robertson currently holds 66,556 shares of Valeant Pharmaceuticals International, Inc. (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Russel C. Robertson has been a net neutral trader of VRX stock. They have purchased $0 and sold $0 worth of shares.
Russel C. Robertson's most recent insider trade was on Dec 30, 2016, when they sold 2,324 shares at $14.52 per share.
Get notified when new Form 4 filings are submitted
| $24.55 |
| Discretionary |
| Jun 30, 2016 | VRX | $6.3K | Award | 312 | $20.14 | Discretionary |
| Jun 17, 2016 | VRX | $0 | Award | 16,726 | $N/A | Discretionary |